Key result
Laparoscopic sleeve gastrectomy resulted in 10.2% greater excess weight loss compared to Roux-en-Y gastric bypass (MD 10.2; 95% CI -10.14 to -9.90).
Why the study?
It was unclear whether laparoscopic sleeve gastrectomy is more effective than laparoscopic Roux-en-Y gastric bypass for weight loss in morbid obesity patients.
Does laparoscopic sleeve gastrectomy improve weight loss compared to Roux-en-Y laparoscopic gastric bypass in morbid obesity patients?
Meta-Analysis
Does laparoscopic sleeve gastrectomy improve weight loss compared to Roux-en-Y laparoscopic gastric bypass in morbid obesity patients?
Laparoscopic sleeve gastrectomy is associated with greater excess weight loss, better comorbidity resolution, and fewer complications compared to Roux-en-Y gastric bypass in morbidly obese patients.
Supports preferring LSG over RYLGB for greater excess weight loss in morbid obesity; strengthens meta-analytic evidence guiding bariatric procedure selection.
BACKGROUND: Bariatric surgery is the most effective option to reduce weight in morbid obesity patients. The techniques most employed are the restrictive surgery laparoscopic sleeve gastrectomy (LSG), surgical procedures of intestinal malabsorption, and both types (restrictive and intestinal malabsorption) such as the Roux-en-Y laparoscopic gastric bypass (RYLGB). AIMS: To determine if LSG is more effective than RYLGB for weight loss. METHODS: A systematic review and meta-analysis was carried out, including five clinical trials and sixteen cohorts comparing LSG versus RYLGB in weight loss and secondary outcomes: resolution of comorbidities, postoperative complications, operative time, hospital stay, and improvement in quality of life. RESULTS: Excess weight loss was 10.2% (mean difference [MD] 10.2; 95%CI -10.14; -9.90) higher in patients undergoing LSG than in patients submitted to RYLGB. Diabetes mellitus type 2 was resolved in 17% (relative risk [RR] 0.83; 95%CI 0.77-0.90) of cases, more significantly after LSG, arterial hypertension in 23% (RR 0.77; 95%CI 0.69-0.84), and dyslipidemia in 17% (RR 0.83; 95%CI 0.77-0.90). Postoperative complications were 73% higher in patients undergoing RYLGB (MD 0.73; 95%CI 0.63-0.83). The operative time was 35.76 minutes shorter in the LSG (MD -35.76; 95%CI -37.28; -34.24). Finally, the quality of life improved more in patients operated by LSG (MD 0.37; 95%CI -0.48; -0.26). CONCLUSIONS: The study demonstrated that LSG could be more effective than RYLGB in reducing the percentage of excess weight, comorbidities, postoperative complications, operative time, hospital stay, and in improving quality of life.
No takes yet. Share an insight, caveat, or question.
GARCÍA-HONORES et al. (2023) conducted a meta-analysis in Morbid obesity. Laparoscopic sleeve gastrectomy (LSG) vs. Roux-en-Y laparoscopic gastric bypass (RYLGB) was evaluated on Excess weight loss (MD 10.2, 95% CI -10.14; -9.90). Laparoscopic sleeve gastrectomy resulted in 10.2% greater excess weight loss compared to Roux-en-Y gastric bypass (MD 10.2; 95% CI -10.14 to -9.90).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: